Viracta Therapeutics, Inc. (VIRX) Reports In-Line Q3 EPS
Tweet
Share
E-mailGet Alerts VIRX Hot Sheet
Join SI Premium – FREE
Viracta Therapeutics, Inc. (NASDAQ: VIRX) reported Q3 EPS of ($0.27), in-line with the analyst estimate of ($0.27).
For earnings history and earnings-related data on Viracta Therapeutics, Inc. (VIRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BTIG Starts ORIC Pharmaceuticals (ORIC) at Buy
- Nike (NKE) PT Raised to $55 at BTIG
- Oppenheimer Starts Virtus Investment Partners (VRTS) at Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
